Jeffrey Weinstein

494 total citations
18 papers, 357 citations indexed

About

Jeffrey Weinstein is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Jeffrey Weinstein has authored 18 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Hepatology and 3 papers in Surgery. Recurrent topics in Jeffrey Weinstein's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (7 papers) and Hepatitis C virus research (6 papers). Jeffrey Weinstein is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (7 papers) and Hepatitis C virus research (6 papers). Jeffrey Weinstein collaborates with scholars based in United States. Jeffrey Weinstein's co-authors include Göran B. Klintmalm, Marlon F. Levy, Robert M. Goldstein, Natalie Murray, George J. Netto, Carlos G. Fasola, Jeffrey S. Crippin, Edmund Q. Sanchez, F. O. Ogunji and Kenneth D. Fine and has published in prestigious journals such as Gastroenterology, The American Journal of Medicine and Journal of Hepatology.

In The Last Decade

Jeffrey Weinstein

16 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey Weinstein United States	10	262	229	180	57	38	18	357
Marie-Claude Becker France	7	183 0.7×	156 0.7×	286 1.6×	64 1.1×	17 0.4×	10	478
A.S. Lok United States	9	194 0.7×	188 0.8×	78 0.4×	44 0.8×	16 0.4×	19	298
Praveer Rai India	12	146 0.6×	128 0.6×	278 1.5×	36 0.6×	17 0.4×	81	436
Arturo Pérez‐Mota Spain	5	271 1.0×	242 1.1×	46 0.3×	53 0.9×	11 0.3×	7	352
J. Rakela United States	10	321 1.2×	280 1.2×	80 0.4×	5 0.1×	23 0.6×	24	401
Jeremy Rajanayagam Australia	8	199 0.8×	162 0.7×	154 0.9×	4 0.1×	24 0.6×	15	391
Chuan‐Hao Lin United States	10	270 1.0×	261 1.1×	111 0.6×	59 1.0×	2 0.1×	15	476
Cécile Denié France	9	239 0.9×	151 0.7×	182 1.0×	13 0.2×	2 0.1×	15	329
P. Stroppa Italy	8	151 0.6×	108 0.5×	160 0.9×	3 0.1×	23 0.6×	21	272
Orlee R. Guttman Canada	9	141 0.5×	169 0.7×	178 1.0×	16 0.3×	3 0.1×	16	293

Countries citing papers authored by Jeffrey Weinstein

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Weinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Weinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Weinstein more than expected).

Fields of papers citing papers by Jeffrey Weinstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Weinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Weinstein. The network helps show where Jeffrey Weinstein may publish in the future.

Co-authorship network of co-authors of Jeffrey Weinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Weinstein. A scholar is included among the top collaborators of Jeffrey Weinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Weinstein. Jeffrey Weinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Weinstein, Jeffrey, et al.. (2025). Ruxolitinib for Emergency Treatment of COVID‐19–Associated Cytokine Storm: Findings From an Expanded Access Study. The Clinical Respiratory Journal. 19(4). e70050–e70050.

Weinstein, Jeffrey, et al.. (2023). S3789 A Rare Case of Sinusoidal Obstruction Syndrome After Pembrolizumab Therapy. The American Journal of Gastroenterology. 118(10S). S2436–S2436.

Modi, Apurva A., et al.. (2017). Excellent cure rates in largest ESRD patient cohort who completed treatment with full dose, daily sofosbuvir-based regimens. Journal of Hepatology. 66(1). S507–S507. 1 indexed citations

Modi, Apurva A., James F. Trotter, Manjushree Gautam, et al.. (2015). Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis. Liver Transplantation. 22(3). 281–286. 26 indexed citations

Mantry, Parvez, et al.. (2012). 837 Early Virologic Response in Patients With HCV Recurrence After Liver Transplant Treated With Triple Therapy: A Single Center Experience. Gastroenterology. 142(5). S–931. 2 indexed citations

Ghalib, Reem, F. Blaine Hollinger, Risë Stribling, et al.. (2009). S1006 Increased LFTS/Clinical Liver Failure in Post OLT Patients Being Treated with Pegifn Alfa-2B Plus Ribavirin for Recurrent Hepatitis C. Gastroenterology. 136(5). A–811. 1 indexed citations

Tanrıöver, Bekir, Alejandro Mejia, Jeffrey Weinstein, et al.. (2008). Analysis of Kidney Function and Biopsy Results in Liver Failure Patients With Renal Dysfunction: A New Look to Combined Liver Kidney Allocation in the Post-MELD Era. Transplantation. 86(11). 1548–1553. 31 indexed citations

Kowdley, Kris V., David J. Brandhagen, Robert G. Gish, et al.. (2005). Survival After Liver Transplantation in Patients With Hepatic Iron Overload: The National Hemochromatosis Transplant Registry. Gastroenterology. 129(2). 494–503. 6 indexed citations

Murray, Natalie, et al.. (2004). Pseudohypocalcemia after magnetic resonance imaging with gadolinium in patients with cirrhosis. Liver Transplantation. 10(1). 136–140. 7 indexed citations

10.

Weinstein, Jeffrey, et al.. (2004). Two-stage total hepatectomy and liver transplantation for acute deterioration of chronic liver disease: A new bridge to transplantation. Liver Transplantation. 10(4). 564–570. 18 indexed citations

11.

Onaca, Nicholas, Marlon F. Levy, George J. Netto, et al.. (2003). Pretransplant MELD Score As a Predictor of Outcome After Liver Transplantation for Chronic Hepatitis C. American Journal of Transplantation. 3(5). 626–630. 61 indexed citations

12.

Molmenti, Ernesto P., Jeffrey Weinstein, Eric E. Elliott, et al.. (2003). Syndromic Incidence of Ovarian Carcinoma After Liver Transplantation, with Special Reference to Anteceding Breast Cancer. Digestive Diseases and Sciences. 48(1). 187–189. 11 indexed citations

13.

Theodore, Dickens, Mitchell L. Shiffman, Richard K. Sterling, et al.. (2003). Intensive Interferon Therapy Does Not Increase Virological Response Rates in African Americans with Chronic Hepatitis C. Digestive Diseases and Sciences. 48(1). 140–145. 17 indexed citations

14.

Sanchez, Edmund Q., Marlon F. Levy, Robert M. Goldstein, et al.. (2003). The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation. 76(11). 1583–1588. 72 indexed citations

15.

Bedimo, Roger & Jeffrey Weinstein. (2003). Recurrent extraintestinal clostridium difficile infection. The American Journal of Medicine. 114(9). 770–771. 15 indexed citations

16.

Fine, Kenneth D., et al.. (2001). Celiac sprue: another autoimmune syndrome associated with hepatitis C. The American Journal of Gastroenterology. 96(1). 138–145. 62 indexed citations

17.

Fine, Kenneth D., et al.. (2000). Celiac sprue: Another autoimmune syndrome associated with hepatitis C. Gastroenterology. 118(4). A697–A697. 1 indexed citations

18.

Weinstein, Jeffrey, John J. Poterucha, Nizar N. Zein, et al.. (1995). Epidemiology and natural history of hepatitis C infections in liver transplant recipients.. PubMed. 22(1 Suppl). 154–9. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact